August 14, 2022
1 minute read
NuVasive Inc. reported increased net sales in its second quarter 2022 financial results, according to a company press release.
The company reported net revenue of $310.5 million for the quarter, an increase of 5.3% from $294.8 million in the year-ago period. NuVasive also reported gross profit of $224.7 million.
“We are encouraged by our revenue growth in the second quarter, driven by procedural volumes, new product launches and the continued global execution of our growth strategies,” Chris Barry, CEO of NuVasive, said in the release. “As surgeons seek differentiated technologies to enable smarter surgery, our C360 portfolio, X360 portfolio and Pulse platform will continue to support our innovation strategy. As we navigate the macro environmental pressures faced by many businesses, we remain focused on our commitment to delivering value to all stakeholders – and most importantly, to changing the lives of more patients around the world.